Comparison of 25-hydroxy vitamin D with FBG and 2 hours postprandial glucose between type 2 diabetic and healthy normoglycemic individuals

Nusrat Jahan; Fatema Sarker; Anzuman Akter; Samira; Sadia Hassan; Mohammad Rafiqul Islam

doi:10.18203/2320-6012.ijrms20252391

Authors

Nusrat Jahan Department of Biochemistry, Kumudini Women's Medical College, Tangail, Bangladesh
Fatema Sarker Department of Biochemistry, Dr. Sirajul Islam Medical College, Dhaka, Bangladesh
Anzuman Akter Department of Biochemistry, Kumudini Women's Medical College, Tangail, Bangladesh
Samira Department of Biochemistry, Shaheed Monsur Ali Medical College, Dhaka, Bangladesh
Sadia Hassan Department of Biochemistry, Kumudini Women's Medical College, Tangail, Bangladesh
Mohammad Rafiqul Islam Department of Pediatrics, Chandpur Medical College, Chandpur, Bangladesh

DOI:

https://doi.org/10.18203/2320-6012.ijrms20252391

Keywords:

Dyslipidemia, Glycemic control, Lipid profile, Type 2 diabetes mellitus, Vitamin D, 25(OH)D

Abstract

ABSTRACT

Background: Vitamin D plays a crucial role in glucose metabolism and lipid regulation. This study aimed to evaluate the association between serum vitamin D levels and glycemic as well as lipid profiles in individuals with and without type 2 diabetes mellitus (T2DM).

Methods: This cross-sectional study was conducted at the Clinical Biochemistry and Biochemistry & Cell Biology Departments of BIRDEM General Hospital, Dhaka, from July 2014 to June 2015. A total of 200 participants aged between 30 and 70 years were selected from the outpatient department, including both type 2 diabetic patients and healthy, non-diabetic individuals. Participants were divided into two groups: Group A comprised 130 type 2 diabetic patients and Group B included 70 healthy normoglycemic controls. A purposive (convenient) sampling technique was used.

Results: The mean serum 25(OH)D level was significantly lower in T2DM patients (22.37±8.34 ng/ml) compared to controls (28.92±10.46 ng/ml; p<0.001). In the diabetic group, vitamin D levels showed significant inverse correlations with fasting glucose, HbA1c and postprandial glucose. Additionally, serum 25 (OH)D was negatively correlated with total cholesterol, LDL and triglycerides and positively with HDL cholesterol. No significant correlations were observed in the non-diabetic group.

Conclusions: Vitamin D deficiency is more prevalent in individuals with T2DM and is significantly associated with poor glycemic control and atherogenic lipid profiles. These findings highlight the potential role of vitamin D in the metabolic regulation of diabetic patients and suggest the need for further interventional studies.

Metrics

Metrics Loading ...

References

Putri SH, Aprilia D, Decroli E. Correlation of serum 25-hydroxyvitamin d levels with glycemic control in type 2 diabetes mellitus patients. J Endocrinol, Trop Med Infect Dis. 2025;5;7(2):69-76.

Begum N. Effect of Vitamin D Supplementation on Glucose Homeostasis among Type 2 Diabetic Patients: A Randomized Clinical Trial (Doctoral dissertation, © University of Dhaka). 2024.

Shet SK. Study of Correlation of Serum Levels of Vitamin-D and Vascular Endothelial Growth Factor in Type 2 Diabetes Mellitus on Oral Hypoglycemic Drugs with 5 Years Duration (Doctoral dissertation, Rajiv Gandhi University of Health Sciences (India)), 2017.

Rathiga A. A study to assess the effect of vitamin D3 supplementation on level of blood glucose among vitamin D deficient adult with prediabetes. 2023.

Adams JS, Hewison M. Extrarenal expression of the 25-hydroxyvitamin D-1-hydroxylase. Archives of biochemistry and biophysics. 2012;523(1):95-102. DOI: https://doi.org/10.1016/j.abb.2012.02.016

Lips P, Hosking D, Lippuner K, Norquist JM, Wehren L, Maalouf G, et al. The prevalence of vitamin D inadequacy amongst women with osteoporosis: an international epidemiological investigation. J Int Med. 2006;260(3):245-54. DOI: https://doi.org/10.1111/j.1365-2796.2006.01685.x

Colledge NR, Walker BR, Ralston S, Davidson LS. Davidson's principles and practice of medicine. Medicine. 2014;2:56-9.

Jorde R, Figenschau Y, Hutchinson M, Emaus N, Grimnes G. High serum 25-hydroxyvitamin D concentrations are associated with a favorable serum lipid profile. European J Clin Nutr. 2010;64(12):1457-64. DOI: https://doi.org/10.1038/ejcn.2010.176

Arunabh S, Pollack S, Yeh J, Aloia JF. Body fat content and 25-hydroxyvitamin D levels in healthy women. J Clin Endocrinol Metabol. 2003;88(1):157-61. DOI: https://doi.org/10.1210/jc.2002-020978

Rahman AS, Sohel MA, Bhuiyan FR, Ashrafee FA, Hossain MK, Islam SF, et al. Serum vitamin D associated with insulin secretory function in impaired fasting glucose subjects. J Biosci Med. 2018;28;7(1):83-98. DOI: https://doi.org/10.4236/jbm.2019.71008

Rabinovitch A, Suarez-Pinzon WL, Sooy K, Strynadka K, Christakos S. Expression of calbindin-D28k in a pancreatic Isletβ-Cell line protects against cytokine-induced apoptosis and necrosis. Endocrinology. 2001;142(8):3649-55. DOI: https://doi.org/10.1210/endo.142.8.8334

Scragg R, Sowers M, Bell C. Serum 25-hydroxyvitamin D, diabetes and ethnicity in the third national health and nutrition examination survey. Diabetes care. 2004;27(12):2813-8. DOI: https://doi.org/10.2337/diacare.27.12.2813

Subramanian A, Nigam P, Misra A, Pandey RM, Mathur M, Gupta R, et al. Severe vitamin D deficiency in patients with Type 2 diabetes in north India. Diabetes Manag. 2011;1;1(5):477. DOI: https://doi.org/10.2217/dmt.11.38

Nemerovski CW, Dorsch MP, Simpson RU, Bone HG, Aaronson KD, Bleske BE. Vitamin D and cardiovascular disease. Pharmacoth J Human Pharmacol Drug Ther. 2009;29(6):691-708. DOI: https://doi.org/10.1592/phco.29.6.691

Wang W, Zhang J, Wang H, Wang X, Liu S. Vitamin D deficiency enhances insulin resistance by promoting inflammation in type 2 diabetes. Int J Clin Exp Pathol. 2019;12(5):1859.

Bhosle DS, Mubeen MF. Evaluation of effect of vitamin D supplementation on glycemic control in patients of type 2 diabetes mellitus. J Diabetes Metab. 2018;1;9(10):1-2. DOI: https://doi.org/10.4172/2155-6156.1000806

Ahdal J, Radhakrishnan C, Joseraj MG, KM PK, George B, Yacoob FL. Vitamin D status and glycemic control in type 2 diabetes mellitus. J Med Sci Clin Res. 2017;5(10):29614-9. DOI: https://doi.org/10.18535/jmscr/v5i10.189

Hu Z, Chen JA, Sun X, Wang L, Wang A. Efficacy of vitamin D supplementation on glycemic control in type 2 diabetes patients: a meta-analysis of interventional studies. Medicine. 2019;98(14):14970. DOI: https://doi.org/10.1097/MD.0000000000014970

Kandeel HT, Sayed DM, Ahmed EH. The relationship between vitamin D deficiency and NAFLD in sample of Egyptian type 2 diabetic patients. Egyptian J Hospital Med. 2019;77(3):5161-6. DOI: https://doi.org/10.21608/ejhm.2019.52406

Atalay E, Korlaelçi F, Gürsoy G, Karabağ Y, Yildiz M, Erdoğdu Hi, et al. The possible effect of vitamin d on uric acid levels in diabetic patients. World Clin J Med Sci. 2017;1(2):77-83. DOI: https://doi.org/10.5336/worldclin.2017-55375

Dutta D, Maisnam I, Shrivastava A, Sinha A, Ghosh S, Mukhopadhyay P, et al. Serum vitamin-D predicts insulin resistance in individuals with prediabetes. Indian J Med Res. 2013;138(6):853-60.

Shu H, Pei Y, Chen K, Lu J. Significant inverse association between serum osteocalcin and incident type 2 diabetes in a middle‐aged cohort. Diabetes/Metabol Res Rev. 2016;32(8):867-74. DOI: https://doi.org/10.1002/dmrr.2808

Mahmood DA, Nanakali NM, Ali KA. Impact of Vitamin D on Glycemic and Metabolic Markers. Passer J Basic Appl Sci. 2025;7(1):153-61.

Syed Khaja AS, Binsaleh NK, Beg MM, Ashfaq F, Khan MI, Almutairi MG, et al. Clinical importance of cytokine (IL-6, IL-8 and IL-10) and vitamin D levels among patients with Type-1 diabetes. Scientific Reports. 2024;14(1):24225. DOI: https://doi.org/10.1038/s41598-024-73737-6